Galectin Therapeutics
Price & Volume
Stats
See moreOpen | $2.30 |
Previous Close | $2.23 |
Day Range | $2.24-$2.39 |
52W Range | $1.21-$7.13 |
Market Cap | $146.7M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.48 |
News
See moreYahoo Finance • 5 months ago
Galectin Advances Belapectin Program With FDA Feedback And Secures $10 Million Credit Line
Yahoo Finance • 6 months ago
Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update
Yahoo Finance • 8 months ago
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Yahoo Finance • 10 months ago
Freeman buys Galectin therapeutics (GALT) stock worth $14,495
About
CEO | Mr. Joel Lewis CPA |
CFO | Mr. Jack W. Callicutt CPA |
Address | 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |